tm
Seeing Is Believing
tm
Seeing Is Believing
TLIS is currently covered by 1 analysts with an average price target of $10.07. This is a potential upside of $0.87 (9.46%) from yesterday's end of day stock price of $9.2.
Talis Biomedical Corp's activity chart (see below) currently has 5 price targets and 5 ratings on display. The stock rating distribution of TLIS is 100% SELL.
Analysts average stock forecasts to be materialized ratio is 79.17% with an average time for these price targets to be met of 182 days.
Highest price target for TLIS is $5, Lowest price target is $5, average price target is $10.07.
Most recent stock forecast was given by MARK MASSARO from BTIG on 16-Aug-2023. First documented stock forecast 09-Mar-2021.
Currently out of the existing stock ratings of TLIS, 1 are a SELL (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
5
$-4 (-44.44%)
15
8 months 8 days ago
2/3 (66.67%)
$-1.83 (-26.79%)
58
Sell
22.5
$13.5 (150.00%)
45
2 years 1 months 8 days ago
2/2 (100%)
$3 (15.38%)
7
Hold
7
$1.95 (38.61%)
7
2 years 6 months 23 days ago
2/2 (100%)
$0.85 (13.73%)
645
Buy
9
$3.95 (78.22%)
13
2 years 8 months 12 days ago
1/2 (50%)
$1.45 (14.69%)
18
What is TLIS (Talis Biomedical Corp) average time for price targets to be met?
Which analyst has the current highest performing score on TLIS (Talis Biomedical Corp) with a proven track record?
Which analyst has the current lower performing score on TLIS (Talis Biomedical Corp) with a proven track record?
Which analyst has the most public recommendations on TLIS (Talis Biomedical Corp)?
Which analyst is the currently most bullish on TLIS (Talis Biomedical Corp)?
Which analyst is the currently most reserved on TLIS (Talis Biomedical Corp)?
